Compare CLOV & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLOV | TRIN |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | 106 |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | N/A |
| Metric | CLOV | TRIN |
|---|---|---|
| Price | $2.06 | $15.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $2.90 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 5.2M | 1.2M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 13.16% |
| EPS Growth | ★ 38.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,924,308,000.00 | N/A |
| Revenue This Year | $52.59 | $30.41 |
| Revenue Next Year | $15.37 | $10.00 |
| P/E Ratio | ★ N/A | $7.18 |
| Revenue Growth | ★ 40.34 | N/A |
| 52 Week Low | $1.58 | $13.75 |
| 52 Week High | $3.92 | $17.20 |
| Indicator | CLOV | TRIN |
|---|---|---|
| Relative Strength Index (RSI) | 63.27 | 62.81 |
| Support Level | $1.96 | $14.31 |
| Resistance Level | $2.25 | $16.34 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | 0.04 | 0.11 |
| Stochastic Oscillator | 92.52 | 97.65 |
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Trinity Capital Inc is an internally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, capital appreciation through investments across five distinct vertical markets. The company is focused on achieving its investment objective by operating as a specialty lending company that provides debt, including loans, equipment financings, and asset-based lending, to growth-oriented companies, including institutional investor-backed companies. Its investment portfolio mainly comprises private companies that have begun to have success selling their products to the market and need additional capital to expand their operations and sales.